Telomir Pharmaceuticals, Inc.
TELO • NASDAQ • Stock Fundamentals
Telomir Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Erez Aminov, with a market cap of $88.7M.
Market Cap$88.7M
CEOErez Aminov
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
Telomir Pharmaceuticals, Inc. FAQ
Common questions about Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. (TELO) has a market capitalization of $88.7M and trades on NASDAQ.